Back to results
US 2024/0180884 A1Published application
Pyridostigmine for use in the treatment of covid-19
OwnerSergio Ivan VALDES FERRERinventor
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of pyridostigmine or a pharmaceutically acceptable salt thereof for the treatment of COVID-19.
Claims6
The use of pyridostigmine or a pharmaceutically acceptable salt thereof for the treatment of SEVERE COVID-19.
Pyridostigmine or a pharmaceutically acceptable salt thereof for use in the treatment of COVID-19.
Dependencies are inferred from the claim text.